Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control

Xin Wanga Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Kaiyuan Denga Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Cheng Wanga Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Yao Lia Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Tianqi Wanga Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Zhi Huanga Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Yakun Maa Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, ChinaView further author information

Peiqing Suna Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, China;e Department of Cancer Biology, Wake Forest Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC, USAView further author information

Yi Shia Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, China;b 2011 Project Collaborative Innovation Center for Biotherapy of Ministry of Education, Tianjin, ChinaView further author information

Shengyong Yangd Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, ChinaView further author information

Yan Fana Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, China;b 2011 Project Collaborative Innovation Center for Biotherapy of Ministry of Education, Tianjin, ChinaCorrespondence[email protected]
View further author information

Rong Xianga Department of Medicinal Chemistry, School of Medicine, Nankai University, Tianjin, China;b 2011 Project Collaborative Innovation Center for Biotherapy of Ministry of Education, Tianjin, China;c State Key Laboratory of Medicinal Chemical Biology, Tianjin, ChinaCorrespondence[email protected]
View further author information

show all

Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Novel CDKs inhibitors for the treatment of solid tumour by simultaneously regulating the cell cycle and transcription control

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date